Serum Institute to invest $68 mn in UK vaccine-maker Oxford Biomedica

British cell therapy firm makes announcement.

Vaccine producer Serum Institute of India will invest 50 million pounds ($68.24 million) in Oxford Biomedica, one of the Covid-19 vaccine manufacturers for drug major AstraZeneca, the British cell therapy firm said on Wednesday.